London-based Sable Bio raises €1.7 million pre-seed to provide scientists with richer specialist data

Published on February 6, 2024

Sable Bio, an innovative B2B software startup changing how biotech and pharma companies evaluate drug target safety for effective decision-making, announced the successful closure of an oversubscribed €1.7 million pre-seed funding round, led by Episode1 Ventures and supported by Seedcamp.  The company is currently seeking to establish partnerships with biotech, pharma, and healthtech companies, as…

This content is for members only. Visit the site and log in/register to read.

The post London-based Sable Bio raises €1.7 million pre-seed to provide scientists with richer specialist data appeared first on EU-Startups.

Continue reading on website
Other news

London-based Unfabled gets €1.4 million to crack the women’s health and wellness market

February 6, 2024
Unfabled, a leading destination for women’s health and wellbeing, announced a €1.4 million round to address the gender health gap, taking its total funding to €1.8 million. The round will be used to expand the consumer-facing platform as well as develop its in-house data science, a core element of its B2B offering.  Prominent investors joined… This content is for members only. Visit the site and l

Barcelona-based Domma snaps €950k to digitise support during menopausal transition

February 6, 2024
Domma, a menopause research, treatment and support startup, has closed a financing round of €950k, between a capital increase and debt, which highlights the growth and potential of the company. The operation has been led by Secways and has once again included the participation of Antai Ventures. Likewise, the Barcelona company has had the support… This content is for members only. Visit the site a